Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
about
Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyTranscatheter Closure of Patent Foramen Ovale: A Single Center Experience.Recent advances in preventing stroke recurrence.Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke.To close or not to close: contemporary indications for patent foramen ovale closure.Cardiac diagnostic work-up of ischaemic stroke.Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).Juvenile StrokeRetrieval of Embolized Amplatzer Patent Foramen Ovale Occlusion Device: Issues Related to Late Recognition.Percutaneous patent foramen ovale closure for cryptogenic stroke: learning from clinical trial and error.Clinical Relevance of Patent Foramen Ovale and Atrial Septum Aneurysm in Stroke: Findings of a Single-Center Cross-Sectional Study.Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical StudyPFO closure: End of an era or beginning of a new chapter?The association between aortic regurgitation and undetermined embolic infarction with aortic complex plaque.Correspondence (letter to the editor): The Interventional Effect Cannot Be Interpreted.Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.Correspondence (reply): In Reply:.Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: Meta-Analysis of Five Randomized Controlled Trials with 3440 Patients.Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guidelinePatent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidencePatent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trialsPatent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke preventionAdvances in Stroke PreventionPatent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trialsCardioembolic stroke: everything has changed
P2860
Q30248752-8E99CFFE-5C33-408D-8C6D-693455593156Q33168074-44CDEBB1-DF55-401D-BAA8-79FBD5B652C2Q33873364-DB273D88-CFDA-4CB6-89DB-71D29D06568EQ38399480-2D42EC31-5475-4978-8AA5-6FCCC8A97328Q38951501-571D1B1A-670C-4696-B797-F8DD1786348DQ39005904-11619CE6-3346-465D-8FEB-9E98ECA4AA9DQ39434381-12A0D7FC-BDE4-41C9-B99A-24058DD18E57Q42043771-16F4F23A-2BF7-40D5-A0D0-D62016B2DFA2Q42253381-6F4D496F-FD54-41BA-89E4-649D1FB151CCQ47148234-1DD284F3-8C63-4AB7-BA94-B36BDB5D4425Q47257812-2D1BC410-3D89-4EAF-8689-C6A7F0DD79BFQ47660182-CFE0A0FA-2449-4E83-9327-2E42C2ED0939Q47678298-C3F690C2-4DC0-419D-AA85-48615A143471Q48062407-DDF590B1-516F-4FD6-8A71-F8EDACD6FDD8Q48126789-67C51AA7-CF43-4073-A5A1-9A074931B863Q49403037-95FE1539-CB30-41D0-8D96-87E2AA46C9CDQ49887613-DBFE3C14-C24D-4D6B-AA9A-A98F3F2C30D8Q50143498-22A99389-A863-44E5-BB40-2EDBA023C647Q51733405-DDF05DF2-23F9-4634-8454-C17932027936Q53832627-E28DCDA5-D5A1-4CA2-9334-C982BF35D25FQ55363978-EE483F25-3344-4889-A23D-7A87438A8DDCQ55505555-989DAAE9-06DA-4CAA-9DD0-018122D578A0Q56566721-AB9C00AB-AB83-48A7-9B95-B243D6E49727Q56804853-D640BCC3-FB99-4BF9-87D8-0AA5D52E6B5DQ57150942-0BAC6B47-258C-46BE-B4DA-2C170560E50BQ57652832-73D04E37-13BB-4B1C-9FB8-2F080EA2CEC7Q58695665-410B44B3-54F9-4EF2-A419-6C5D87314D5CQ58706609-3643E9D3-BD63-4C12-89F3-A08E50516967Q58769055-D6FFD08F-91A9-4ABA-BA78-FCE62B157E1E
P2860
Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@ast
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@en
type
label
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@ast
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@en
prefLabel
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@ast
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@en
P2093
P2860
P1476
Device Closure of Patent Foram ...... f Completed Randomized Trials.
@en
P2093
Anthony J Furlan
Bernhard Meier
David E Thaler
David M Kent
Heinrich P Mattle
Issa J Dahabreh
Jeffrey L Saver
John D Carroll
Mark Reisman
Richard W Smalling
P2860
P304
P356
10.1016/J.JACC.2015.12.023
P407
P50
P577
2016-03-01T00:00:00Z